Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Gisondi

Showing results (41-50 of 69) with videos related to

Pageof 7
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV|April 21, 2026
Practical recommendations for seborrheic dermatitis management: An expert consensusL Naldi, A Kyrgidis, G S Tiplica, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 28, 2014
Efficacy of a fixed combination of calcipotriol/betamethasone dipropionate topical gel in adult patients with mild to moderate psoriasis: blinded interim analysis of a phase IV, multicenter, randomized, controlled, prospective studyK Reich, I Zschocke, H Bachelez, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 6, 2014
PSOCUBE, a multidimensional assessment of psoriasis patients as a both clinically/practically sustainable and evidence-based algorithmD Linder, G Altomare, S Amato, et al.
The British Journal of Dermatology|May 8, 2013
Survival rate of antitumour necrosis factor-α treatments for psoriasis in routine dermatological practice: a multicentre observational studyM Esposito, P Gisondi, N Cassano, et al.
The British Journal of Dermatology|March 17, 2017
A Topical Treatment Optimization Programme (TTOP) improves clinical outcome for calcipotriol/betamethasone gel in psoriasis: results of a 64-week multinational randomized phase IV study in 1790 patients (PSO-TOP)K Reich, I Zschocke, H Bachelez, et al.
The Australasian Journal of Dermatology|April 3, 2025
Exploring the Impact of Guselkumab and Risankizumab on Psoriasis in HIV-Positive Patients: Insights From Four Italian CentersV Maione, S Rovaris, C Romanó, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 2, 2017
Dose adjustment of biologic therapies for psoriasis in dermatological practice: a retrospective studyM Esposito, P Gisondi, A Conti, et al.
La Clinica Terapeutica|November 23, 2023
X-linked genodermatoses from diagnosis to tailored therapyM C Medori, P Gisondi, F Bellinato, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 9, 2011
Psodisk, a new visual method for assessing the burden of psoriasis on patientsD Linder, F Sampogna, A Torreggiani, et al.
The Journal of Dermatological Treatment|November 17, 2015
Effectiveness and safety of cyclosporine in pediatric plaque psoriasis: A multicentric retrospective analysisV Di Lernia, L Stingeni, V Boccaletti, et al.
Pageof 7

Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
Journal of the European Academy of Dermatology and Venereology : JEADV|April 21, 2026
Practical recommendations for seborrheic dermatitis management: An expert consensusL Naldi, A Kyrgidis, G S Tiplica, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 28, 2014
Efficacy of a fixed combination of calcipotriol/betamethasone dipropionate topical gel in adult patients with mild to moderate psoriasis: blinded interim analysis of a phase IV, multicenter, randomized, controlled, prospective studyK Reich, I Zschocke, H Bachelez, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 6, 2014
PSOCUBE, a multidimensional assessment of psoriasis patients as a both clinically/practically sustainable and evidence-based algorithmD Linder, G Altomare, S Amato, et al.
The British Journal of Dermatology|May 8, 2013
Survival rate of antitumour necrosis factor-α treatments for psoriasis in routine dermatological practice: a multicentre observational studyM Esposito, P Gisondi, N Cassano, et al.
The British Journal of Dermatology|March 17, 2017
A Topical Treatment Optimization Programme (TTOP) improves clinical outcome for calcipotriol/betamethasone gel in psoriasis: results of a 64-week multinational randomized phase IV study in 1790 patients (PSO-TOP)K Reich, I Zschocke, H Bachelez, et al.
The Australasian Journal of Dermatology|April 3, 2025
Exploring the Impact of Guselkumab and Risankizumab on Psoriasis in HIV-Positive Patients: Insights From Four Italian CentersV Maione, S Rovaris, C Romanó, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 2, 2017
Dose adjustment of biologic therapies for psoriasis in dermatological practice: a retrospective studyM Esposito, P Gisondi, A Conti, et al.
La Clinica Terapeutica|November 23, 2023
X-linked genodermatoses from diagnosis to tailored therapyM C Medori, P Gisondi, F Bellinato, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 9, 2011
Psodisk, a new visual method for assessing the burden of psoriasis on patientsD Linder, F Sampogna, A Torreggiani, et al.
The Journal of Dermatological Treatment|November 17, 2015
Effectiveness and safety of cyclosporine in pediatric plaque psoriasis: A multicentric retrospective analysisV Di Lernia, L Stingeni, V Boccaletti, et al.
Pageof 7